Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AGRX

Agile Therapeutics Inc

Dec 07 • 02:08PM ET

2.28

Dollar change -0.02
Percentage change -0.87	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-13.10	Insider Own	5.99%	Shs Outstand	2.51M	Perf Week	8.06%
Market Cap	5.72M	Forward P/E	2.92	EPS next Y	0.78	Insider Trans	0.00%	Shs Float	2.36M	Perf Month	13.44%
Income	-13.93M	PEG	-	EPS next Q	-0.40	Inst Own	5.88%	Short Float / Ratio	0.76% / 0.41	Perf Quarter	8.58%
Sales	19.97M	P/S	0.29	EPS this Y	94.57%	Inst Trans	-	Short Interest	0.02M	Perf Half Y	-36.27%
Book/sh	-5.45	P/B	-	EPS next Y	115.60%	ROA	-94.90%	Target Price	5.00	Perf Year	-75.77%
Cash/sh	1.14	P/C	1.99	EPS next 5Y	-	ROE	-2554.11%	52W Range	1.65 - 16.00	Perf YTD	-79.91%
Dividend	-	P/FCF	-	EPS past 5Y	49.72%	ROI	-	52W High	-85.75%	Beta	1.78
Dividend %	-	Quick Ratio	0.44	Sales past 5Y	122.59%	Gross Margin	57.75%	52W Low	38.19%	ATR	0.22
Employees	22	Current Ratio	0.57	Sales Q/Q	121.92%	Oper. Margin	-113.70%	RSI (14)	57.30	Volatility	14.87% 10.89%
Optionable	No	Debt/Eq	-	EPS Q/Q	98.98%	Profit Margin	-69.73%	Rel Volume	0.90	Prev Close	2.30
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 09 BMO	Payout	-	Avg Volume	43.69K	Price	2.28
Recom	1.00	SMA20	8.04%	SMA50	13.43%	SMA200	-49.55%	Volume	28,667	Change	-0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$8
Apr-12-19	Resumed	Janney	Buy	$4
Nov-29-18	Initiated	Maxim Group	Buy	$3
Dec-26-17	Downgrade	William Blair	Outperform → Mkt Perform
Dec-26-17	Downgrade	Janney	Buy → Neutral
Oct-02-17	Resumed	H.C. Wainwright	Buy	$10
Sep-14-17	Reiterated	RBC Capital Mkts	Outperform	$8 → $10
Jul-19-17	Initiated	H.C. Wainwright	Buy	$10
Jan-08-16	Initiated	Cantor Fitzgerald	Buy
Apr-02-15	Initiated	FBR Capital	Outperform	$17
Jun-17-14	Initiated	William Blair	Outperform
Jun-17-14	Initiated	RBC Capital Mkts	Outperform	$12

Show Previous Ratings

Nov-22-23 09:00AM	Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 (ACCESSWIRE)
Nov-10-23 10:20AM	Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:17AM	Agile Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
08:05AM	Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-26-23 08:05AM	Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023 (GlobeNewswire)
04:30PM	Loading…
Oct-04-23 04:30PM	Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-28-23 04:19PM	Why Shares of Agile Therapeutics Jumped This Week (Motley Fool)
09:00AM	Agile Therapeutics (NASDAQ: AGRX) Upgraded To Buy Rating By Analysts At Maxim Group (ACCESSWIRE)
Sep-22-23 09:38AM	Wayfair upgraded, Deere downgraded: Wall Street's top analyst calls (The Fly)
Sep-05-23 08:05AM	Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-17-23 09:00AM	Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter (ACCESSWIRE)
Aug-11-23 09:35AM	Agile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-09-23 08:14AM	Agile Therapeutics: Q2 Earnings Snapshot (Associated Press Finance) -11.19%
08:05AM	Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-26-23 08:30AM	Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023 (GlobeNewswire)
09:00AM	Loading…
Jul-19-23 09:00AM	This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys (ACCESSWIRE)
Jul-18-23 09:00AM	Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women (ACCESSWIRE)
Jul-11-23 09:15AM	Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Bidens Latest Executive Order Expanding Contraceptive Coverage (ACCESSWIRE)
Jul-05-23 09:00AM	H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch (ACCESSWIRE) +9.57%
Jul-03-23 09:00AM	This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023 (ACCESSWIRE)
Jun-30-23 09:00AM	Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About? (ACCESSWIRE) +12.60%
Jun-28-23 09:00AM	The Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Care (ACCESSWIRE)
Jun-27-23 03:36PM	President Bidens new executive order could help American women get better birth control (Fortune) -8.42%
Jun-26-23 08:01AM	Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members (GlobeNewswire)
Jun-23-23 12:05PM	Agile Therapeutics Commends the Biden Administrations Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services (GlobeNewswire)
Jun-15-23 04:05PM	Agile Therapeutics Announces the Availability of Twirla® through FPA Womens Health (GlobeNewswire) -6.61%
Jun-14-23 11:29AM	Why Agile Therapeutics Stock Is Trading Higher Today (Benzinga)
Jun-13-23 04:05PM	Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla® (GlobeNewswire)
May-25-23 04:05PM	Agile Therapeutics Announces Closing of $7.5 Million Public Offering (GlobeNewswire) -6.46%
May-22-23 08:00PM	Agile Therapeutics Announces Pricing of $7.5 Million Public Offering (GlobeNewswire) -6.55%
06:29AM	Loading…
May-12-23 06:29AM	Q1 2023 Agile Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.97%
May-11-23 04:43PM	Agile Therapeutics: Q1 Earnings Snapshot (AP Finance)
04:05PM	Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update (GlobeNewswire)
May-08-23 08:00AM	Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 (GlobeNewswire) +7.63%
Apr-28-23 08:01AM	Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023 (GlobeNewswire)
Apr-26-23 09:01AM	Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Apr-10-23 04:30PM	Agile Therapeutics Announces 1-For-50 Reverse Stock Split (GlobeNewswire) -10.17%
Apr-05-23 05:30AM	Birth control fail: Why American women cant have better contraceptives in 2023 (Fortune)
Mar-27-23 02:25AM	Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-23-23 12:49PM	Q4 2022 Agile Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -9.33%
Mar-22-23 04:05PM	Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +10.56%
Mar-21-23 09:05AM	Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023 (GlobeNewswire) +14.90%
Feb-27-23 08:31AM	Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement (GlobeNewswire)
Feb-20-23 09:40AM	Are Medical Stocks Lagging Ardelyx (ARDX) This Year? (Zacks)
Feb-15-23 08:00AM	Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financial Officer (PR Newswire) +7.41%
Feb-09-23 08:00AM	Corium Pharma Solutions Names Two Industry Veterans to its Executive Team (PR Newswire)
Feb-03-23 09:40AM	Is Ardelyx (ARDX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-01-23 08:01AM	Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation (GlobeNewswire)
Jan-26-23 04:30PM	Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock (GlobeNewswire)
Jan-20-23 08:45AM	Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women (News Direct)
Jan-18-23 09:40AM	Is Ardelyx (ARDX) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-09-23 07:00AM	Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan (GlobeNewswire) +6.85%
Dec-21-22 09:05AM	This Biotech Company is Pursuing Positive Cash Flow In 2023 (News Direct)
Dec-01-22 08:30AM	Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference (GlobeNewswire)
Nov-15-22 08:15AM	Womens Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow (News Direct) +5.59%
Nov-07-22 04:05PM	Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +19.39%
Oct-26-22 08:30AM	Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022 (GlobeNewswire)
08:00AM	Can This Companys Birth Control Patch Disrupt The Contraceptive Market? (News Direct)
Oct-21-22 11:00AM	NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 (News Direct)
Oct-07-22 04:25PM	Agile Therapeutics Announces Reorganization of Leadership Team (GlobeNewswire) -10.06%
Sep-06-22 08:30AM	Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 09:30PM	Agile Therapeutics (AGRX) Q2 2022 Earnings Call Transcript (Motley Fool)
04:05PM	Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-28-22 08:05AM	Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022 (GlobeNewswire)
Jul-26-22 03:47PM	Woman-Health Focused Stock Agile Therapeutics Is 'Better Positioned,' Analyst Says While Upgrading Stock (Benzinga) +8.22%
Jul-14-22 08:45AM	10 Best Penny Stocks to Buy in July (Insider Monkey) -9.62%
Jul-12-22 02:33PM	HC Wainwright Sees Agile Therapeutics' Twirla Tailwinds Post Roe-Wade Ruling (Benzinga)
10:55AM	Agile Therapeutics Tightens Q2 Forecast For Contraceptive Patch 'Twirla' (Benzinga)
08:05AM	Agile Therapeutics Updates Second Quarter 2022 Guidance (GlobeNewswire)
Jul-08-22 08:05AM	Agile Therapeutics to Participate in Maxim Groups Upcoming Womens Health Panel (GlobeNewswire) -5.52%
Jul-06-22 05:16PM	Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering (GlobeNewswire)
Jul-01-22 09:20AM	Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering (GlobeNewswire) -45.03%
Jun-28-22 09:58AM	Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism (GlobeNewswire) +89.76%
May-17-22 08:01AM	Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference (GlobeNewswire) -7.14%
May-13-22 12:00AM	Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript (Motley Fool)
May-12-22 04:05PM	Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
May-05-22 05:01PM	Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation (GlobeNewswire) -7.39%
May-03-22 07:30AM	Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022 (GlobeNewswire) -8.00%
Apr-26-22 10:46AM	BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism (GlobeNewswire) -17.54%
08:00AM	Agile Therapeutics Announces 1-For-40 Reverse Stock Split (GlobeNewswire)
Apr-19-22 09:53AM	Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Womens Health, Autism, Glaucoma, and Cancer Therapeutics (GlobeNewswire) -10.03%
Apr-14-22 07:30AM	Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla® (GlobeNewswire) -13.10%
Apr-11-22 07:05AM	Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program (GlobeNewswire) -13.26%
Apr-07-22 07:30AM	Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG) (GlobeNewswire)
Mar-31-22 07:30AM	Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z (GlobeNewswire) -12.67%
Mar-30-22 11:00PM	Agile Therapeutics (AGRX) Q4 2021 Earnings Call Transcript (Motley Fool) -7.66%
05:25PM	Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-23-22 05:45PM	Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-14-22 06:07PM	Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering (GlobeNewswire) -8.69%
08:00AM	Agile Therapeutics Announces $4.85 Million Registered Direct Offering (GlobeNewswire)
Mar-11-22 08:01AM	Agile Therapeutics to Participate in Upcoming March Investor Events (GlobeNewswire) -6.58%
Mar-10-22 05:55PM	Amphastar Pharmaceuticals (AMPH) Tops Q4 Earnings and Revenue Estimates (Zacks)
Mar-07-22 08:01AM	Agile Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Wednesday, March 30, 2022 (GlobeNewswire) -9.64%
Feb-24-22 06:00PM	Personalis (PSNL) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +5.23%
Feb-15-22 10:14AM	10 Cheap Pharmaceutical Stocks For 2022 (Insider Monkey) +7.62%
Jan-31-22 05:38PM	Dumont & Blake Investment Advisors Llc Buys Cassava Sciences Inc, PRA Group Inc, Corteva ... (GuruFocus.com) +6.92%
Jan-21-22 01:38PM	Founders Capital Management Buys iShares TIPS Bond ETF, AT&T Inc, Vanguard Health Care ETF, ... (GuruFocus.com) -10.45%
Jan-12-22 05:29PM	Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman and Her Heathcare Provider Determine are Medically Appropriate at No Cost (GlobeNewswire)
Jan-10-22 08:01AM	Agile Therapeutics and Afaxys Partner to Expand Access to Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System (GlobeNewswire) -11.21%

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AGRX

Agile Therapeutics Inc

Upgrade your FINVIZ experience